Mkts

Lucid Diagnostics Inc.

NASDAQ: LUCD
$0.46-0.04 (-7.33%)
As of Oct 27, 12:44 PM ET

Key statistics

Day range
0.450.55
52-week range
0.301.63
Today
Open0.51
Previous close0.46
Volume2.34M
Valuation
Market cap101.76M
P/E ratio—
EPS (TTM)-0.38
Income & risk
Dividend / yield—
Beta1.21
Avg volume3.39M
Discussion

LUCD News

Stories mentioning LUCD from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue(3,202)1,2111,163828.001,1971,172976.00
Cost of Goods Sold1,6251,551
Gross Profit(1,625)(723.00)
Operating Expenses
Research & Development1,2061,7231,2721,2551,4281,4531,6661,372
Sales General & Admin
Total Operating Expenses12,97012,54713,31513,57112,86612,168
Operating Income (Loss)(12,114)(14,010)(11,759)(11,384)(12,487)(12,374)(11,694)(11,192)
Interest Income70.0066.00
Interest Expense2.006.009.007.001.006.00
Other Expense1,3626,945(14,421)833.00(677.00)187.00
Pretax Income(13,909)(16,266)(10,397)(4,439)(26,908)(11,541)(12,371)(11,005)
Tax Provision0.000.00
Net Income (Loss)(13,909)(16,266)(10,397)(4,439)(26,908)(11,541)(12,371)(11,005)
Earnings Per Share (Basic)(0.17)(0.16)(0.10)(0.08)(0.52)(0.23)(0.25)(0.23)
Earnings Per Share (Diluted)(0.10)(0.08)(0.52)(0.23)(0.25)(0.23)
Weighted Average Shares Outstanding (Basic)140,097101,947108,17698,98968,79650,51650,37448,212
Weighted Average Shares Outstanding (Diluted)108,17698,98968,79650,51650,37448,212

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About LUCD

Lucid Diagnostics Inc. (NASDAQ: LUCD) is a stock listed on the Nasdaq Stock Market under the ticker symbol LUCD. It last traded at $0.4600 (Oct 27, 2026, 12:44 PM ET), down 7.3% on the day. That gives Lucid Diagnostics a market capitalisation of $101.8M.

Over the past 52 weeks LUCD has traded between $0.3000 and $1.63.

For the quarter ended Mar 31, 2026 it reported a net loss of $13.9M.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026—-$13.9M—
Dec 31, 2025-$3.2M-$16.3M—
Sep 30, 2025$1.2M-$10.4M-858.5%
Jun 30, 2025$1.2M-$4.4M-381.7%

From Lucid Diagnostics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…